Glycan targeting can recruit anti-tumor immunologic functions by lymphatic endothelium.

Dash A, Johns SC, Moleta C, Zúñiga EI, Fuster MM

DOI: 10.1016/j.neo.2026.101340
Published: 2026 Oct
Container: Neoplasia (New York, N.Y.)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.neo.2026.101340,
  title = {Glycan targeting can recruit anti-tumor immunologic functions by lymphatic endothelium.},
  author = {Dash A and Johns SC and Moleta C and Zúñiga EI and Fuster MM},
  year = {2026},
  journal = {Neoplasia (New York, N.Y.)},
  doi = {10.1016/j.neo.2026.101340},
  url = {https://doi.org/10.1016/j.neo.2026.101340}
}

RIS

TY  - JOUR
TI  - Glycan targeting can recruit anti-tumor immunologic functions by lymphatic endothelium.
AU  - Dash A
AU  - Johns SC
AU  - Moleta C
AU  - Zúñiga EI
AU  - Fuster MM
PY  - 2026
JO  - Neoplasia (New York, N.Y.)
DO  - 10.1016/j.neo.2026.101340
UR  - https://doi.org/10.1016/j.neo.2026.101340
ER  -

APA

A, D., SC, J., C, M., EI, Z., & MM, F. (2026). Glycan targeting can recruit anti-tumor immunologic functions by lymphatic endothelium.. Neoplasia (New York, N.Y.). https://doi.org/10.1016/j.neo.2026.101340

Source records

pubmed · retrieved 2026-09-26T04:22:38.708Z